Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. - Scheurer ME; Zhou R; Gilbert MR; Bondy ML; Sulman EP; Yuan Y; Liu Y; Vera E; Wendland MM; Youssef EF; Stieber VW; Komaki RR; et al. (Neuro-oncology advances, 2022)